Inventor · disambiguated record
Alex Levitzki
Also filed as: KABBINAVAR FAIROOZ F · LEVITZKI ALEX · ORFI LASZLO
9 granted patents·1 pending application·589 citations·filing 1995–2022
91Inventor score
Top patents by PatentIndex Score
10 records- 0195US5990141ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Nov 23, 1999·189 cites·20 claims
- 0295US5851999AFLK-1 is a receptor for vascular endothelial growth factorMAX PLANCK GESELLSCHAFT·Filed 1995·Granted Dec 22, 1998·160 cites·32 claims
- 0391US6331555B1Treatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1999·Granted Dec 18, 2001·152 cites·15 claims
- 0488US5700822ATreatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1995·Granted Dec 23, 1997·67 cites·24 claims
- 0587US10543232B2Polyplex of double-stranded RNA and polymeric conjugateTARGIMMUNE THERAPEUTICS AG·Filed 2019·Granted Jan 28, 2020·8 cites·23 claims
- 0683US10278991B2Polyethyleneimine polyethyleneglycol vectorsTARGIMMUNE THERAPEUTICS AG·Filed 2015·Granted May 7, 2019·5 cites·25 claims
- 0780US11298376B2Method of treating cancerTARGIMMUNE THERAPEUTICS AG·Filed 2019·Granted Apr 12, 2022·1 cites·30 claims
- 0878US6872699B2Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 proteinMAX PLANCK GESELLSCHAFT·Filed 2001·Granted Mar 29, 2005·6 cites·4 claims
- 0971US2022339189A1Method of treating cancerTARGIMMUNE THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1057US7964399B2Cell line comprising vector encoding truncated FLK-1 receptorMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Jun 21, 2011·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Alex Levitzki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →